RestorLife Med review

The markup here is unusually honest — every tier renders its standing figure next to the discounted one, so you can read the real rate without entering the funnel, and the billing cadence is stated per tier rather than left ambiguous. Two separate microdose products, one per molecule, each priced below its full-dose sibling. What to watch is the shape rather than the size: the whole grid sits under a disclaimer that pricing is introductory and subject to change, and on the full-dose product the multi-month figures are blended averages that fold in a half-price first month, so the rate from month two is higher than the number shown.

Vs median

$30/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Charges less for less

Consult

Included in the price

Dietitian

Not included

Labs

Optional

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

RestorLife Med does not publicly identify the pharmacy that fills its prescriptions. Bloodwork is offered but not required. A clinician review is included in the price.

RestorLife Med is a physician-guided telehealth brand selling compounded GLP-1 weight loss in both microdose and full-dose tiers, plus hormone therapy and sermorelin. Clinical care is delivered by Wasef Health under two named board-certified internal-medicine physicians, one of them licensed in all 50 states. The compounding pharmacy is described only as state-licensed and linked in the footer as a partner pharmacy, but never named on the product pages, and no 503A or 503B designation is given. Service is available in all 50 states, though some require a synchronous video consultation before a prescription is issued. Priority shipping is included, and the program bundles up to eight consults, at-home blood draws and lab interpretations before overage fees begin.

On the full-dose product the three- and six-month "now" prices are blended AVERAGES that fold in a half-price first month. The advertised six-month figure works out to roughly $10/mo more than advertised from month two onward, and RestorLife does not say so next to the number

• The entire price grid is discounted roughly 50% under a disclaimer reading that pricing shown is introductory and subject to change, so today's microdose entry price can revert to the standing rate with no notice
• The three-month microdose "was" price does not reconcile with the one-month "was" price as any stated discount, so the anchor prices are internally inconsistent
• No milligram figure is published for what any microdose price buys
• The compounding pharmacy is never named on the product pages and no 503A/503B designation is given
• Buried in the terms: at-home blood draws are charged individually after the eighth, and additional consults and lab interpretations carry a per-event fee — real overage exposure on a program sold as all-inclusive
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

RestorLife Med is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Microdosing semaglutide
• Microdosing tirzepatide
• The true annual cost of a plan
• What a flat price costs at a low dose